Literature DB >> 12593971

The NKG2D receptor and its ligands-recognition beyond the "missing self"?

Carsten Watzl1.   

Abstract

NKG2D is a surface receptor that activates natural killer (NK) cells and delivers a co-stimulatory signal to CD8-positive T cells. The ligands of NKG2D are induced by cellular stress and are specifically expressed by some tumor cells. This sparked the idea of an alternative regulation of NK cells by expression of "induced self" ligands on target cells which can overcome the inhibition imparted by MHC class I-specific inhibitory receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12593971     DOI: 10.1016/s1286-4579(02)00057-6

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  21 in total

1.  Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.

Authors:  Roberto Biassoni; Elisabetta Ugolotti; Andrea De Maria
Journal:  Self Nonself       Date:  2010-03-06

2.  Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.

Authors:  Xiaosan Su; Lei Zhang; Liangkun Jin; Junsong Ye; Zheng Guan; Rui Chen
Journal:  J Clin Immunol       Date:  2010-06-15       Impact factor: 8.317

3.  Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.

Authors:  Xuzhang Lu; Zhichao Zhu; Lijia Jiang; Xiao Sun; Zhuxia Jia; Sixuan Qian; Jianyong Li; Lingdi Ma
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 4.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

5.  Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer.

Authors:  Hiroaki Saito; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Gastric Cancer       Date:  2011-05-31       Impact factor: 7.370

Review 6.  Role of NKG2D and its ligands in cancer immunotherapy.

Authors:  Huifang Liu; Sijia Wang; Jing Xin; Jing Wang; Cuiping Yao; Zhenxi Zhang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

7.  NKp44 expression, phylogenesis and function in non-human primate NK cells.

Authors:  Andrea De Maria; Elisabetta Ugolotti; Erik Rutjens; Stefania Mazza; Luana Radic; Alessandro Faravelli; Gerrit Koopman; Eddi Di Marco; Paola Costa; Barbara Ensoli; Aurelio Cafaro; Maria Cristina Mingari; Lorenzo Moretta; Jonathan Heeney; Roberto Biassoni
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

8.  Ozone exposed epithelial cells modify cocultured natural killer cells.

Authors:  Loretta Müller; Luisa E Brighton; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-14       Impact factor: 5.464

9.  Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.

Authors:  Jennifer D Wu; Lily M Higgins; Alexander Steinle; David Cosman; Kathy Haugk; Stephen R Plymate
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells.

Authors:  Jutta Steigerwald; Tobias Raum; Stefan Pflanz; Ronny Cierpka; Susanne Mangold; Doris Rau; Patrick Hoffmann; Majk Kvesic; Christina Zube; Stefanie Linnerbauer; John Lumsden; Mirnaalini Sriskandarajah; Peter Kufer; Patrick A Baeuerle; Jörg Volkland
Journal:  MAbs       Date:  2009-03-11       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.